Opus Genetics (IRD) Debt Ratio (2019 - 2026)
Opus Genetics (IRD) reported Debt Ratio of 0.02 for Q1 2026, down 93.2% year-over-year from 0.26 in Q1 2025, and down 20.17% on a QoQ basis from 0.02 in Q4 2025.
Opus Genetics (IRD) has 5 years of Debt Ratio data on file, last reported at 0.02 in Q1 2026.
- Quarterly Debt Ratio fell 93.2% year-over-year to 0.02 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02 (down 93.2% YoY) and the FY2025 annual result came in at 0.02, changed N/A from the prior year.
- Debt Ratio fell to 0.02 in Q1 2026 per IRD's latest filing, from 0.02 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.62 in Q3 2025 and bottomed at 0.0 in Q3 2023.
- The 4-year median for Debt Ratio is 0.02 (2025), against an average of 0.18.
- Peak annual rise in Debt Ratio reached 93.2% in 2026, while the deepest fall reached 93.2% in 2026.
- Tracing IRD's Debt Ratio over 4 years: stood at 0.01 in 2022, then tumbled by 83.65% to 0.0 in 2023, then soared by 1209.37% to 0.02 in 2025, then decreased by 20.17% to 0.02 in 2026.
- Per Business Quant, the three latest IRD Debt Ratio figures stand at 0.02 (Q1 2026), 0.02 (Q4 2025), and 0.62 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.18 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 1.41 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.05 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | 0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.62 |
| Jun 30, 2025 | 0.33 |
| Mar 31, 2025 | 0.26 |
| Sep 30, 2023 | 0.00 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2019 | 1.52 |